Solesence, Inc.
SLSN Nasdaq· Perfumes, Cosmetics & Other Toilet Preparations
Last close · Oct 26, 2026
$0.77
KIRA · Stoqly’s AI analyst, in plain words
- Solesence, Inc. had $62.1M of revenue in fiscal 2025, up 18.6% on the year before. Over five years, revenue changed +29.4% a year on average.
- Its operating margin was 2.5%, down 7.3 pts: of every 100 in sales, about 3 is left after running the business.
- Solesence, Inc. made $1.8M of net profit in fiscal 2025.
Market cap
$54.4M
P/E
—
Revenue
$62.1M
Net income
$1.8M
Free cash flow
—
Operating margin
2.5%
Solesence, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+18.6%
Yes. Sales grew 18.6% last year.
Does it make a profit?
2.9%
A little. It keeps 2.9% of every sale as profit.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Solesence, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 31, 2026
- Legal name
- SOLESENCE, INC.
- CIK
- 0000883107
Solesence, Inc. · SLSN
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $29.5M | $37.3M | $37.3M | $52.3M | $62.1M |
| Revenue growth | 72.1% | 26.6% | −0.1% | 40.4% | 18.6% |
| Gross margin | 29.5% | 22.4% | 21.0% | 30.9% | 25.9% |
| Operating margin | 8.7% | −6.1% | −9.5% | 9.8% | 2.5% |
| Net income | $2.3M | −$2.6M | −$4.4M | $4.2M | $1.8M |
| Net margin | 7.9% | −7.0% | −11.8% | 8.1% | 2.9% |
| Diluted EPS | $0.05 | −$0.05 | −$0.09 | $0.07 | $0.02 |
| Cash | |||||
| Cash from operations | $2.3M | −$1.7M | −$2.0M | $2.0M | −$8.6M |
| Capital expenditure | $1.9M | $2.8M | $1.1M | $4.6M | — |
| Free cash flow | $0.4M | −$4.5M | −$3.1M | −$2.6M | — |
| FCF margin | 1.5% | −12.0% | −8.2% | −4.9% | — |
| Share count change | 22.0% | 4.4% | 0.9% | 31.2% | 11.6% |
| Debt and strength | |||||
| Cash and short-term investments | $0.7M | $2.2M | $1.7M | $1.4M | $1.3M |
| Debt incl. finance leases | $1.1M | $1.0M | — | — | — |
| Shareholders' equity | $7.5M | $5.6M | $1.9M | $10.4M | $14.1M |
| Net debt / EBITDA | 0.2x | — | — | — | — |
| Current ratio | 1.6x | 1.2x | 1.0x | 1.1x | 1.8x |
| Interest coverage | 2.2x | −5.9x | −4.2x | 7.7x | — |
| Returns and quality | |||||
| Return on capital | 32.3% | −40.0% | — | — | — |
| Return on equity | 45.5% | −40.0% | −116.3% | 69.1% | 14.6% |
| Return on tangible equity | 31.1% | −46.4% | −230.8% | 40.9% | 12.7% |
| Piotroski F-score | 6 | 3 | 2 | 5 | 3 |
| Altman Z'' | −9.2 | −9.4 | −10.9 | −5.1 | −4.9 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Solesence, Inc. · SLSN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.77 a share, the company is worth $54.4M.
Source: SEC EDGAR XBRL filings (CIK 0000883107). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.